RNS Number : 5196T
Persimmon PLC
20 July 2020
20 July 2020
Persimmon Plc (the "Company")
Director/PDMR Shareholding
On 16 July 2020, Dave Jenkinson, Group Chief Executive, sold 50,000 shares in the Company at a price of £26.216709 per share.
Following this transaction, Dave Jenkinson holds 733,290 shares in the Company including 108,937 and 44,791 shares to be held until at least 15 October 2020 and 3 June 2021 respectively.
The below notification, made in accordance with the requirements of article 19.3 of the EU Market Abuse Regulation, gives further details:
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
a)
|
Name
|
Dave Jenkinson
|
2
|
Reason for the notification
|
a)
|
Position/status
|
Group Chief Executive
|
b)
|
Initial notification /Amendment
|
Initial notification
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
a)
|
Name
|
Persimmon Plc
|
b)
|
LEI
|
213800XI72Y57UWN6F31
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
a)
|
Description of the financial instrument, type of instrument
|
Ordinary shares of 10p each
|
|
|
Identification code
|
GB0006825383
|
|
|
b)
|
Nature of the transaction
|
Sale of shares
|
c)
|
Price(s) and volume(s)
|
|
|
|
|
|
|
Price(s)
|
Volume(s)
|
|
|
|
£26.216709
|
50,000
|
|
|
|
|
|
|
d)
|
Aggregated information
|
|
|
|
- Aggregated volume
|
N/A Single transaction
|
|
|
- Price
|
N/A Single transaction
|
|
|
e)
|
Date of the transaction
|
16/07/2020
|
f)
|
Place of the transaction
|
London Stock Exchange (XLON), Main Market
|
Tracy Davison
Company Secretary
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com or visit
www.rns.com.
END
DSHEAAXEALXEEFA